Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD56 (clone rHlgM1G2E). We employs the pUC (lac-Cy3-c-Jun-KpnI) vector components and the SynExpress system of the miRNA Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
CD56
Clone
rHlgM1G2E
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
lac
Effector Gene
c-Jun
Insertion Sites
KpnI
Gene Modification
Knock-in
Modification Domain
miRNA
Carrier Type
pUC
Transformation Accuracy
0.85
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.